Skip to main content

Main menu

  • Home
  • Content
    • Current Issue
    • Past Issues
    • Accepted Articles
    • Email Alerts
    • RSS
    • Terms of Use
  • About PDA JPST
    • JPST Editors and Editorial Board
    • About/Vision/Mission
    • Paper of the Year
  • Author & Reviewer Resources
    • Author Resources / Submit
    • Reviewer Resources
  • JPST Access and Subscriptions
    • PDA Members
    • Institutional Subscriptions
    • Nonmember Access
  • Support
    • Join PDA
    • Contact
    • Feedback
    • Advertising
    • CiteTrack
  • .
    • Visit PDA
    • PDA Letter
    • Technical Reports
    • news uPDATe
    • Bookstore

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
PDA Journal of Pharmaceutical Science and Technology
  • .
    • Visit PDA
    • PDA Letter
    • Technical Reports
    • news uPDATe
    • Bookstore
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
PDA Journal of Pharmaceutical Science and Technology

Advanced Search

  • Home
  • Content
    • Current Issue
    • Past Issues
    • Accepted Articles
    • Email Alerts
    • RSS
    • Terms of Use
  • About PDA JPST
    • JPST Editors and Editorial Board
    • About/Vision/Mission
    • Paper of the Year
  • Author & Reviewer Resources
    • Author Resources / Submit
    • Reviewer Resources
  • JPST Access and Subscriptions
    • PDA Members
    • Institutional Subscriptions
    • Nonmember Access
  • Support
    • Join PDA
    • Contact
    • Feedback
    • Advertising
    • CiteTrack
  • Follow pda on Twitter
  • Visit PDA on LinkedIn
  • Visit pda on Facebook
Research ArticleTechnology/Application

In Vitro Screening Methods To Assess the Potential of In Vivo Precipitation of Injectable Formulations upon Intravenous Administration

Agam R. Sheth
PDA Journal of Pharmaceutical Science and Technology January 2011, 65 (1) 71-80;
Agam R. Sheth
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • References
  • Info & Metrics
  • PDF
Loading

References

  1. 1.↵
    1. Yalkowski S. H.
    1. Yalkowski S. H.,
    2. Roseman T. J.
    Chapter 3. Solubilization of Drugs by Cosolvents. In Techniques of Solubilization of Drugs; Yalkowski S. H., Ed.; Marcel Dekker: New York, 1981.
  2. 2.↵
    1. Schroeder H. G.,
    2. DeLuca P. P.
    A study on the in vivo precipitation of poorly soluble drugs from nonaqueous vehicles in human plasma. Bull. Parenter. Drug Assoc. 1974, 28 (1), 1–14.
    OpenUrlPubMed
  3. 3.↵
    1. Yalkowski S. H.,
    2. Valvani S. C.,
    3. Johnson B. W.
    In vitro method for detecting precipitation of parenteral formulations after injection. J. Pharm. Sci. 1983, 72 (9), 1014–1017.
    OpenUrlCrossRefPubMed
  4. 4.↵
    1. Yalkowski S. H.
    1. Repta A. J.
    Chapter 4. Alteration of Apparent Solubility through Complexation. In Techniques of Solubilization of Drugs; Yalkowski S. H., Ed.; Marcel Dekker: New York, 1981.
  5. 5.↵
    1. Davio S. R.,
    2. Mc Shane M. M.,
    3. Kakuk T. J.,
    4. Zaya R. M.,
    5. Cole S L.
    Precipitation of the rennin inhibitor ditekiren upon IV infusion; in vitro studies and their relationship to in vivo precipitation in the Cynomolgus monkey. Pharm. Res. 1991, 8 (1), 80–83.
    OpenUrlPubMed
  6. 6.↵
    1. Greenfield J. C.,
    2. Loux S. J.,
    3. Sood V. K.,
    4. Jenkins K. M.,
    5. Davio S. M.
    In vitro evaluation of the plasma and blood compatibility of a parenteral formulation for ditekiren, a novel rennin inhibitor pseudopeptide. Pharm. Res. 1991, 8 (4), 475–479.
    OpenUrlPubMed
  7. 7.↵
    1. Cox J. W.,
    2. Sage G. P.,
    3. Wynalda M. A.,
    4. Ulrich R. G.,
    5. Larson P. G.,
    6. Su C. C.
    Plasma compatibility of injectables: comparison of intravenous U-74006F, a 21-aminosteroid antioxidant, with Dilantin brand of parenteral phenytoin. J. Pharm. Sci. 1991, 80 (4), 371–375.
    OpenUrlPubMed
  8. 8.↵
    1. Myrdal P. B.,
    2. Simamora P.,
    3. Surakitbanharn Y.,
    4. Yalkowski S. H.
    Studies in phlebitis. VII: In vitro and in vivo evaluation of pH solubilized levenmopamil. J. Pharm. Sci. 1995, 84 (7), 849–852.
    OpenUrlPubMedWeb of Science
  9. 9.↵
    1. Simamora P.,
    2. Pinsuwan S.,
    3. Surakitbanham Y.,
    4. Yalkowski S. H.
    Studies in phlebitis. VIII: Evaluations of pH solubilized intravenous dexverapamil formulations. PDA J. Pharm. Sci. Technol. 1996, 50 (2), 123–128.
    OpenUrlAbstract/FREE Full Text
  10. 10.↵
    1. Johnson J. L. H.,
    2. Yalkowsky S. H.
    Reformulation of a new vancomycin analog: an example of the importance of buffer species and strength. AAPS PharmSciTech 2006, 7 (1), E1–E5.
    OpenUrlPubMed
  11. 11.↵
    1. Jencks W. P.
    Catalysis in Chemistry and Enzymology; Mc-Graw Hill: New York, 1969; pp 358–392.
  12. 12.↵
    1. Yalkowski S. H.,
    2. Krzyzaniak J. F.,
    3. Ward G. H.
    Formulation-related problems associated with intravenous drug delivery. J. Pharm. Sci. 1998, 87 (7), 787–796.
    OpenUrlCrossRefPubMedWeb of Science
  13. 13.↵
    1. Portmann G. A.,
    2. Simmons D. M.
    Microscopic determination of drug solubility in plasma and calculation of injection rates with a plasma circulatory model to prevent precipitation on intravenous injection. J. Pharm. Biomed. Anal. 1995, 13 (9), 1189–1193.
    OpenUrlPubMed
  14. 14.↵
    1. Johnson J. L. H.,
    2. He Y.,
    3. Yalkowsky S. H.
    Prediction of precipitation-induced phlebitis: a statistical validation of an in vitro model. J. Pharm. Sci. 2003, 92 (8), 1574–1581.
    OpenUrlPubMed
  15. 15.↵
    1. Ward G. H.,
    2. Yalkowsky S. H.
    The role of effective concentration in interpreting hemolysis data. J. Parenter. Sci. Technol. 1992, 46 (5), 161–162.
    OpenUrlPubMed
  16. 16.↵
    1. Rubino J. T.,
    2. Nellore R.,
    3. Parmar B.
    Dynamic compatibility testing of DMP 840, and experimental antitumor agent. PDA J. Pharm. Sci. Technol. 1997, 51 (3), 130–136.
    OpenUrlAbstract/FREE Full Text
  17. 17.↵
    1. Olson W. P.,
    2. Faith M. R.
    Human serum albumin as a cosolvent for parenteral drugs. J. Parenter. Sci. Technol. 1988, 42 (3), 82–85.
    OpenUrlPubMed
  18. 18.↵
    1. Swarbrick J.,
    2. Boylan J. C.
    1. Rodriguez-Hornedo N.
    Crystallization and the properties of crystals. In Encyclopedia of Pharmaceutical Technology, V3; Swarbrick J., Boylan J. C., Eds.; Marcel Dekker: New York, 1992; pp 399–434.
  19. 19.↵
    1. Ziller K. H.,
    2. Rupprecht H. H.
    Control of crystal growth in drug suspensions. Part 2. Influence of polymers on dissolution and crystallization during temperature cycling. Pharm. Ind. 1990, 52, 1017–1022.
    OpenUrl
  20. 20.↵
    1. Bittner B.,
    2. Mountfield R. J.
    Intravenous administration of poorly soluble new drug entities in early drug discovery: the potential impact of formulation on pharmacokinetic parameters. Curr. Opin. Drug Discov. Devel. 2002, 5 (1), 59–71.
    OpenUrlPubMed
  21. 21.↵
    1. Alvarez-Nunez F. A.,
    2. Yalkowsky S. H.
    Buffer capacity and precipitation control of pH solubilized phenytoin formulations. Int. J. Pharm. 1999, 185 (1), 45–49.
    OpenUrlPubMed
  22. 22.↵
    1. Li P.,
    2. Rao V.,
    3. Tabibi S. E.,
    4. Yalkowsky S. H.
    Evaluation of in vitro precipitation methods. J. Pharm. Sci. 1998, 87 (2), 196–199.
    OpenUrlPubMed
  23. 23.↵
    1. Narazaki R.,
    2. Sanghvi R.,
    3. Yalkowsky S. H.
    Estimation of drug precipitation upon dilution of pH-controlled formulations. Mol. Pharm. 2007, 4 (4), 550–555.
    OpenUrlPubMed
PreviousNext
Back to top

In This Issue

PDA Journal of Pharmaceutical Science and Technology: 65 (1)
PDA Journal of Pharmaceutical Science and Technology
Vol. 65, Issue 1
January/February 2011
  • Table of Contents
  • Index by Author
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on PDA Journal of Pharmaceutical Science and Technology.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
In Vitro Screening Methods To Assess the Potential of In Vivo Precipitation of Injectable Formulations upon Intravenous Administration
(Your Name) has sent you a message from PDA Journal of Pharmaceutical Science and Technology
(Your Name) thought you would like to see the PDA Journal of Pharmaceutical Science and Technology web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
7 + 1 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.
Citation Tools
In Vitro Screening Methods To Assess the Potential of In Vivo Precipitation of Injectable Formulations upon Intravenous Administration
Agam R. Sheth
PDA Journal of Pharmaceutical Science and Technology Jan 2011, 65 (1) 71-80;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
In Vitro Screening Methods To Assess the Potential of In Vivo Precipitation of Injectable Formulations upon Intravenous Administration
Agam R. Sheth
PDA Journal of Pharmaceutical Science and Technology Jan 2011, 65 (1) 71-80;
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • 1. Introduction
    • 2. Materials and Methods
    • 3. Results and Discussion
    • 4. Conclusions
    • 6. Conflict of Interest Declaration
    • 5. Acknowledgements
    • References
  • Figures & Data
  • References
  • Info & Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • Mechanical Container Closure Integrity Test: A Method for Cartridge Systems
  • A Container Closure Integrity Test Method for Vials Stored at Cryogenic Conditions Using Headspace Oxygen Analysis
  • Best Practices for Microbial Challenge In-Use Studies to Evaluate the Microbial Growth Potential of Parenteral Biological Products; Industry and Regulatory Considerations
Show more Technology/Application

Similar Articles

Readers

  • About
  • Table of Content Alerts/Other Alerts
  • Subscriptions
  • Terms of Use
  • Contact Editors

Author/Reviewer Information

  • Author Resources
  • Submit Manuscript
  • Reviewers
  • Contact Editors

Parenteral Drug Association, Inc.

  • About
  • Advertising/Sponsorships
  • Events
  • PDA Bookstore
  • Press Releases

© 2025 PDA Journal of Pharmaceutical Science and Technology Print ISSN: 1079-7440  Digital ISSN: 1948-2124

Powered by HighWire